Article

Mortality Predictors Of Pre-variant SARS-CoV-2 Infected ARDS Patients Receiving Favipiravir and Tocilizumab

2022-05-18

Abstract excerpt

<h4>Objective: </h4> In this study, viral clearance (oronasopharyngeal swab RT-PCR negativity) and intensive care outcomes and risk factors affecting mortality of critically ill patients with COVID-19-related acute respiratory distress syndrome (ARDS) who received tocilizumab and favipiravir treatments together before vaccination were investigated. Material-Methods The data of patients who were followed up and tr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f8f5db99-fa4b-5ea5-a011-ebae35b1b7cf
DOI: 10.21203/rs.3.rs-1666161/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Mortality Predictors Of Pre-variant SARS-CoV-2 Infected ARDS Patients Receiving Favipiravir and TocilizumabDOI 10.21203/rs.3.rs-1666161/v1Read

Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 prospective phase 2 trialSemantic proximity Read

Course of inflammation and infection markers differ in ICU patients with severe COVID-19 under casirivimab- and/or tocilizumab application: an observational studySemantic proximity Read

SARS-CoV2 infection in Symptomatic patients: interest of Serological tests and Predictors of Mortality. Experience of DR CongoSemantic proximity Read

Age as a Significant Factor in the Diagnosis and Prognosis of ARDS Patients Not Meeting the Berlin CriteriaSemantic proximity Read

Mortality Trend of Severe COVID-19 in Under-Vaccinated Population Admitted to ICU in French AmazoniaSemantic proximity Read

Clinical characteristics associated with ARDS and mortality in patients with COVID-19 who received corticosteroid therapySemantic proximity Read

Attributable Causes of Death Among US Veteran Patients within 30-90 days following SARS-CoV-2 Infection: A Nationwide Cohort StudySemantic proximity Read

On whether therapeutic plasma exchange is an effective cure against severe/critical COVID-19 pneumoniaSemantic proximity Read

Clinical Phenotypes from Fatal Cases of Acute Respiratory Distress Syndrome Caused by PneumoniaSemantic proximity Read

Cycle threshold SARS-CoV-2 RT-PCR and bronchoalveolar cytokine concentrations redefine the COVID-19 phenotypes in critically ill patientsSemantic proximity Read

On Whether Therapeutic Plasma Exchange is Effective Against Severe/Critical COVID-19 PneumoniaSemantic proximity Read

Analysis of severe outcomes associated with the SARS-CoV-2 Variant of Concern 202012/01 in England using ICNARC Case Mix Programme and QResearch databasesSemantic proximity Read